J.P. Morgan Private Wealth Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-15,431
| Closed | -$1.05M | – | 2033 |
|
|
2022
Q3 | $1.05M | Sell |
15,431
-2,847
| -16% | -$194K | ﹤0.01% | 1107 |
|
|
2022
Q2 | $584K | Sell |
18,278
-1,460
| -7% | -$46.6K | ﹤0.01% | 1395 |
|
|
2022
Q1 | $684K | Sell |
19,738
-2,289
| -10% | -$79.3K | ﹤0.01% | 1387 |
|
|
2021
Q4 | $645K | Sell |
22,027
-1,196
| -5% | -$35K | ﹤0.01% | 1445 |
|
|
2021
Q3 | $592K | Sell |
23,223
-504
| -2% | -$12.8K | ﹤0.01% | 1434 |
|
|
2021
Q2 | $831K | Sell |
23,727
-13,574
| -36% | -$475K | ﹤0.01% | 1281 |
|
|
2021
Q1 | $1.52M | Sell |
37,301
-2,804
| -7% | -$114K | ﹤0.01% | 871 |
|
|
2020
Q4 | $1.74M | Buy |
40,105
+530
| +1% | +$23K | 0.01% | 790 |
|
|
2020
Q3 | $2.18M | Buy |
39,575
+18,640
| +89% | +$1.03M | 0.01% | 627 |
|
|
2020
Q2 | $1.32M | Buy |
20,935
+424
| +2% | +$26.8K | 0.01% | 707 |
|
|
2020
Q1 | $1.05M | Buy |
20,511
+10,188
| +99% | +$521K | 0.01% | 700 |
|
|
2019
Q4 | $821K | Buy |
10,323
+127
| +1% | +$10.1K | ﹤0.01% | 872 |
|
|
2019
Q3 | $495K | Buy |
10,196
+3,043
| +43% | +$148K | ﹤0.01% | 1009 |
|
|
2019
Q2 | $376K | Sell |
7,153
-1,794
| -20% | -$94.3K | ﹤0.01% | 1072 |
|
|
2019
Q1 | $474K | Buy |
8,947
+854
| +11% | +$45.2K | ﹤0.01% | 1058 |
|
|
2018
Q4 | $332K | Sell |
8,093
-4,595
| -36% | -$189K | ﹤0.01% | 1118 |
|
|
2018
Q3 | $482K | Buy |
12,688
+5,523
| +77% | +$210K | ﹤0.01% | 1085 |
|
|
2018
Q2 | $324K | Hold |
7,165
| – | – | ﹤0.01% | 1178 |
|
|
2018
Q1 | $346K | Sell |
7,165
-619
| -8% | -$29.9K | ﹤0.01% | 996 |
|
|
2017
Q4 | $306K | Buy |
7,784
+163
| +2% | +$6.41K | ﹤0.01% | 1048 |
|
|
2017
Q3 | $237K | Buy |
+7,621
| New | +$237K | ﹤0.01% | 1100 |
|